- Home
- RPRX vs IEX Comparison
RPRX vs IEX Comparison
Compare RPRX & IEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | IEX |
|---|---|---|
| Founded | 1996 | 1987 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4B | 15.8B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RPRX | IEX |
|---|---|---|
| Price | $45.16 | $209.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $47.75 | ★ $228.86 |
| AVG Volume (30 Days) | ★ 4.2M | 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.09% | 1.35% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $39.10 | $4.09 |
| Revenue Next Year | $5.02 | $4.45 |
| P/E Ratio | ★ $25.25 | $32.71 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $29.66 | $153.36 |
| 52 Week High | $46.14 | $217.16 |
Technical Indicators
Market Signals| Indicator | RPRX | IEX |
|---|---|---|
| Relative Strength Index (RSI) | 73.30 | 62.01 |
| Support Level | $42.50 | $204.39 |
| Resistance Level | $46.14 | $212.68 |
| Average True Range (ATR) | 1.00 | 6.01 |
| MACD | 0.19 | -0.43 |
| Stochastic Oscillator | 82.91 | 64.49 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About IEX IDEX Corporation
Idex manufactures pumps, flow meters, valves, and fluidic systems for customers in a variety of end markets, including industrial, fire and safety, life science, and water. The firm's business is organized into three segments: fluid and metering technologies, health and science technologies, and fire and safety and diversified products. Based in Lake Forest, Illinois, Idex has manufacturing operations in over 20 countries and has over 7,000 employees. The company generated $3.5 billion in revenue in 2025.